Naphthalene-induced cataract has been extensively used to test potential anticataract drugs. Because the morphology as well as the toxic manifestations of naphthalene-induced cataract are reported to be similar to that of age-related cataract, naphthalene cataractogenesis in rats has been used as a valuable animal model to study the aetiology of age-related cataract in humans. This study aimed to determine whether the molecular chaperone activity of the α-crystallins was altered in naphthalene-induced cataract, and to clarify the possible mechanism for these changes. The data showed that the chaperone activity of the α-crystallins decreased in naphthalene-induced cataract. By mass spectrometry, C-terminal truncation of 16 amino acids and other post-translational modifications such as acetylation, phosphorylation, oxidation and carbamylation of the α-crystallins were detected. Furthermore, the results suggested that, at the proteomics level, naphthalene-induced cataract is a valuable animal model for the study of age-related cataract in humans.
CongdonNGFriedmanDSLietmanT: Important causes of visual impairment in the world today. JAMA2003; 290: 2057–2060.
2.
KupferC: On presentation of the Friedenwald Award of the Association for Research in Vision and Ophthalmology to Dr Joram Piatigorsky. Invest Ophthalmol Vis Sci1987; 28: 2–8.
3.
ThampiPHassanASmithJB: Enhanced C-terminal truncation of A- and B-crystallins in diabetic lenses. Invest Ophthalmol Vis Sci2002; 43: 3265–3272.
HorwitzJ: Proctor Lecture. The function of alpha-crystallin. Invest Ophthalmol Vis Sci1993; 34: 10–22.
6.
RossaVPauH: Is the experimental naphthalene cataract a model for human senile cataract?. Graefes Arch Clin Exp Ophthalmol1988; 226: 291–293.
7.
PandyaUSainiMKJinGF: Dietary curcumin prevents ocular toxicity of naphthalene in rats. Toxicol Lett2000; 115: 195–204.
8.
SatoSSugiyamaKLeeYS: Prevention of naphthalene-1, 2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors. Exp Eye Res1999; 68: 601–608.
9.
RathbunWBNagasawaHTKillenCE: Prevention of naphthalene-induced cataract and hepatic glutathione loss by the L-cysteine prodrugs, MTCA and PTCA. Exp Eye Res1996; 62: 433–441.
10.
TaoRVTakahashiYKadorP: Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat. Invest Ophthalmol Vis Sci1991; 32: 1630–1637.
11.
ARVO statement on registering clinical trials. Invest Ophthalmol Vis Sci2006; 47: 1–2.
12.
GuojunMW Cao: Dynamic observation and quantificational analysis of galactose-induced cataract using slit lamp microscope image analysis system. China Medical Herald2006; 3: 146–147 [in Chinese].
13.
FujiiNTakeuchiNFujiiN: Comparison of post-translational modifications of alpha A-crystallin from normal and hereditary cataract rats. Amino Acids2004; 26: 147–152.
14.
KelleyMJDavidLLIwasakiN: α-Crystallin chaperone activity is reduced by calpain II in vitro and in selenite cataract. J Biol Chem1993; 268: 18844–18849.
15.
JiaWWuHLuH: Rapid and automatic on-plate desalting protocol for MALDI-MS: Using imprinted hydrophobic polymer template. Proteomics2007; 7: 2497–2506.
16.
ZhengXHongLShiL: Proteomics analysis of host cells infected with infectious bursal disease virus. Mol Cell Proteomics2008; 7: 612–625.
17.
BrusickDSmallMSCavalieriEL: Possible genotoxic modes of action for naphthalene. Regul Toxicol Pharmacol2008; 51 (2 suppl): S43–S50.
18.
TakemotoLEmmonsTHorwitzJ: The C-terminal region of alpha-crystallin: Involvement in protection against heat-induced denaturation. Biochem J1993; 294: 435–438.
19.
UedaYFukiageCShihM: Mass measurements of C-terminally truncated alpha-crystallins from two-dimensional gels identify Lp82 as a major endopeptidase in rat lens. Mol Cell Proteomics2002; 1: 357–365.
20.
NakamuraYFukiageCShihM: Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice. Invest Ophthalmol Vis Sci2000; 41: 1460–1466.
21.
GollDEThompsonVFLiH: The calpain system. Physiol Rev2003; 83: 731–801.
22.
InomataMHayashiMShumiyaS: Aminoguanidine-treatment results in the inhibition of lens opacification and calpain-mediated proteolysis in Shumiya cataract rats (SCR). J Biochem2000; 128: 771–776.
23.
ShearerTRMaHShihM: Calpains in the lens and cataractogenesis. Methods Mol Biol2000; 144: 277–285.
24.
UedaYDuncanMKDavidLL: Lens proteomics: The accumulation of crystallin modifications in the mouse lens with age. Invest Ophthalmol Vis Sci2002; 43: 205–215.
25.
FukiageCAzumaMNakamuraY: Calpain-induced light scattering by crystallins from three rodent species. Exp Eye Res1997; 65: 757–770.
26.
NakajimaTFukiageCAzumaM: Different expression patterns for ubiquitous calpains and Capn3 splice variants in monkey ocular tissues. Biochim Biophys Acta2001; 1519: 55–64.
27.
UedaYMcCormackALShearerTR: Purification and characterization of lens specific calpain (Lp82) from bovine lens. Exp Eye Res2001; 73: 625–637.
28.
AzumaMFukiageCDavidLL: Activation of calpain in lens: A review and proposed mechanism. Exp Eye Res1997; 64: 529–538.
29.
DavidLLVarnumMDLampiKJ: Calpain II in human lens. Invest Ophthalmol Vis Sci1989; 30: 269–275.
30.
SandersonJMarcantonioJMDuncanG: A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification. Invest Ophthalmol Vis Sci2000; 41: 2255–2261.
31.
KameiAHamaguchiTMatsuuraN: Does post-translational modification influence chaperone-like activity of α-crystallin? I. Study on phosphorylation. Biol Pharm Bull2001; 24: 96–99.
32.
van BoekelMAHoogakkerSEHardingJJ: The influence of some post-translational modifications on the chaperone-like activity of alpha-crystallin. Ophthalmic Res1996; 28 (suppl 1): 32–38.
33.
DerhamBKHardingJJ: α-Crystallin as a molecular chaperone. Prog Retin Eye Res1999; 18: 463–509.
34.
Jimenez-AsensioJColvisCMKowalakJA: An atypical form of αB-crystallin is present in high concentration in some human cataractous lenses. Identification and characterization of aberrant N- and C-terminal processing. J Biol Chem1999; 274: 32287–32294.
35.
TakemotoLHorwitzJEmmonsT: Oxidation of the N-terminal methionine of lens alpha-A crystallin. Curr Eye Res1992; 11: 651–655.
36.
HardingJJRixonKC: Carbamylation of lens proteins: A possible factor in cataractogenesis in some tropical countries. Exp Eye Res1980; 31: 567–571.
37.
MelladoWSlebeJCMaccioniRB: Tubulin carbamoylation. Functional amino groups in microtubule assembly. Biochem J1982; 203: 675–681.
38.
LapkoVNSmithDLSmithJB: In vivo carbamylation and acetylation of water-soluble human lens αB-crystallin lysine 92. Protein Sci2001; 10: 1130–1136.
